Year |
Citation |
Score |
2021 |
Balan S, Iwayama Y, Ohnishi T, Fukuda M, Shirai A, Yamada A, Weirich S, Schuhmacher MK, Dileep KV, Endo T, Hisano Y, Kotoshiba K, Toyota T, Otowa T, Kuwabara H, et al. A loss-of-function variant in SUV39H2 identified in autism-spectrum disorder causes altered H3K9 trimethylation and dysregulation of protocadherin β-cluster genes in the developing brain. Molecular Psychiatry. PMID 34262135 DOI: 10.1038/s41380-021-01199-7 |
0.524 |
|
2021 |
Hara T, Toyoshima M, Hisano Y, Balan S, Iwayama Y, Aono H, Futamura Y, Osada H, Owada Y, Yoshikawa T. Glyoxalase I disruption and external carbonyl stress impair mitochondrial function in human induced pluripotent stem cells and derived neurons. Translational Psychiatry. 11: 275. PMID 33966051 DOI: 10.1038/s41398-021-01392-w |
0.477 |
|
2021 |
Ohnishi T, Kiyama Y, Arima-Yoshida F, Kadota M, Ichikawa T, Yamada K, Watanabe A, Ohba H, Tanaka K, Nakaya A, Horiuchi Y, Iwayama Y, Toyoshima M, Ogawa I, Shimamoto-Mitsuyama C, ... ... Balan S, et al. Cooperation of LIM domain-binding 2 (LDB2) with EGR in the pathogenesis of schizophrenia. Embo Molecular Medicine. e12574. PMID 33656268 DOI: 10.15252/emmm.202012574 |
0.595 |
|
2021 |
Balan S, Ohnishi T, Watanabe A, Ohba H, Iwayama Y, Toyoshima M, Hara T, Hisano Y, Miyasaka Y, Toyota T, Shimamoto-Mitsuyama C, Maekawa M, Numata S, Ohmori T, Shimogori T, et al. Role of an Atypical Cadherin Gene, Cdh23 in Prepulse Inhibition, and Implication of CDH23 in Schizophrenia. Schizophrenia Bulletin. PMID 33595068 DOI: 10.1093/schbul/sbab007 |
0.567 |
|
2021 |
Ogata S, Hashizume K, Hayase Y, Kanno Y, Hori K, Balan S, Yoshikawa T, Takahashi H, Taya S, Hoshino M. Potential involvement of DSCAML1 mutations in neurodevelopmental disorders. Genes to Cells : Devoted to Molecular & Cellular Mechanisms. PMID 33501714 DOI: 10.1111/gtc.12831 |
0.511 |
|
2020 |
Wada Y, Maekawa M, Ohnishi T, Balan S, Matsuoka S, Iwamoto K, Iwayama Y, Ohba H, Watanabe A, Hisano Y, Nozaki Y, Toyota T, Shimogori T, Itokawa M, Kobayashi T, et al. Peroxisome proliferator-activated receptor α as a novel therapeutic target for schizophrenia. Ebiomedicine. 103130. PMID 33279456 DOI: 10.1016/j.ebiom.2020.103130 |
0.536 |
|
2020 |
Hayase Y, Amano S, Hashizume K, Tominaga T, Miyamoto H, Kanno Y, Ueno-Inoue Y, Inoue T, Yamada M, Ogata S, Balan S, Hayashi K, Miura Y, Tokudome K, Ohno Y, et al. Down syndrome cell adhesion molecule like-1 (DSCAML1) links the GABA system and seizure susceptibility. Acta Neuropathologica Communications. 8: 206. PMID 33256836 DOI: 10.1186/s40478-020-01082-6 |
0.439 |
|
2020 |
Maekawa M, Ohnishi T, Toyoshima M, Shimamoto-Mitsuyama C, Hamazaki K, Balan S, Wada Y, Esaki K, Takagai S, Tsuchiya KJ, Nakamura K, Iwata Y, Nara T, Iwayama Y, Toyota T, et al. A potential role of fatty acid binding protein 4 in the pathophysiology of autism spectrum disorder. Brain Communications. 2: fcaa145. PMID 33225276 DOI: 10.1093/braincomms/fcaa145 |
0.493 |
|
2020 |
Shimamoto-Mitsuyama C, Nakaya A, Esaki K, Balan S, Iwayama Y, Ohnishi T, Maekawa M, Toyota T, Dean B, Yoshikawa T. Lipid Pathology of the Corpus Callosum in Schizophrenia and the Potential Role of Abnormal Gene Regulatory Networks with Reduced Microglial Marker Expression. Cerebral Cortex (New York, N.Y. : 1991). PMID 32924060 DOI: 10.1093/cercor/bhaa236 |
0.591 |
|
2020 |
Esaki K, Balan S, Iwayama Y, Shimamoto-Mitsuyama C, Hirabayashi Y, Dean B, Yoshikawa T. Evidence for Altered Metabolism of Sphingosine-1-Phosphate in the Corpus Callosum of Patients with Schizophrenia. Schizophrenia Bulletin. PMID 32346731 DOI: 10.1093/schbul/sbaa052 |
0.585 |
|
2020 |
Balan S, Ohnishi T, Watanabe A, Ohba H, Iwayama Y, Hisano Y, Toyota T, Toyoshima M, Shimogori T, Hayashi T, Kikkawa Y, Yoshikawa T. Genetic Deciphering of Prepulse Inhibition Reveals the Putative Role of an Atypical Cadherin in Schizophrenia Pathogenesis Biological Psychiatry. 87: S398. DOI: 10.1016/j.biopsych.2020.02.1017 |
0.375 |
|
2019 |
Ide M, Ohnishi T, Toyoshima M, Balan S, Maekawa M, Shimamoto-Mitsuyama C, Iwayama Y, Ohba H, Watanabe A, Ishii T, Shibuya N, Kimura Y, Hisano Y, Murata Y, Hara T, et al. Excess hydrogen sulfide and polysulfides production underlies a schizophrenia pathophysiology. Embo Molecular Medicine. e10695. PMID 31657521 DOI: 10.15252/Emmm.201910695 |
0.562 |
|
2019 |
Toyoshima M, Jiang X, Ogawa T, Ohnishi T, Yoshihara S, Balan S, Yoshikawa T, Hirokawa N. Enhanced carbonyl stress induces irreversible multimerization of CRMP2 in schizophrenia pathogenesis. Life Science Alliance. 2. PMID 31591136 DOI: 10.26508/lsa.201900478 |
0.537 |
|
2019 |
Ohnishi T, Balan S, Toyoshima M, Maekawa M, Ohba H, Watanabe A, Iwayama Y, Fujita Y, Tan Y, Hisano Y, Shimamoto-Mitsuyama C, Nozaki Y, Esaki K, Nagaoka A, Matsumoto J, et al. Investigation of betaine as a novel psychotherapeutic for schizophrenia. Ebiomedicine. PMID 31255657 DOI: 10.1016/j.ebiom.2019.05.062 |
0.578 |
|
2019 |
Shimamoto-Mitsuyama C, Ohnishi T, Balan S, Ohba H, Watanabe A, Maekawa M, Hisano Y, Iwayama Y, Owada Y, Yoshikawa T. Evaluation of the role of fatty acid-binding protein 7 in controlling schizophrenia-relevant phenotypes using newly established knockout mice. Schizophrenia Research. PMID 30765249 DOI: 10.1016/j.schres.2019.02.002 |
0.584 |
|
2018 |
Maekawa M, Ohnishi T, Balan S, Hisano Y, Nozaki Y, Ohba H, Toyoshima M, Shimamoto C, Tabata C, Wada Y, Yoshikawa T. Thiosulfate promotes hair growth in mouse model. Bioscience, Biotechnology, and Biochemistry. 1-9. PMID 30200826 DOI: 10.1080/09168451.2018.1518705 |
0.391 |
|
2018 |
Balan S, Toyoshima M, Yoshikawa T. Contribution of induced pluripotent stem cell technologies to the understanding of cellular phenotypes in schizophrenia. Neurobiology of Disease. PMID 29729395 DOI: 10.1016/j.nbd.2018.04.021 |
0.579 |
|
2018 |
Shimazu T, Furuse T, Balan S, Yamada I, Okuno S, Iwanari H, Suzuki T, Hamakubo T, Dohmae N, Yoshikawa T, Wakana S, Shinkai Y. Role of METTL20 in regulating β-oxidation and heat production in mice under fasting or ketogenic conditions. Scientific Reports. 8: 1179. PMID 29352221 DOI: 10.1038/s41598-018-19615-4 |
0.415 |
|
2017 |
Maekawa M, Watanabe A, Iwayama Y, Kimura T, Hamazaki K, Balan S, Ohba H, Hisano Y, Nozaki Y, Ohnishi T, Toyoshima M, Shimamoto C, Iwamoto K, Bundo M, Osumi N, et al. Polyunsaturated fatty acid deficiency during neurodevelopment in mice models the prodromal state of schizophrenia through epigenetic changes in nuclear receptor genes. Translational Psychiatry. 7: e1229. PMID 28872641 DOI: 10.1038/Tp.2017.182 |
0.406 |
|
2017 |
Balan S, Yamada K, Iwayama Y, Hashimoto T, Toyota T, Shimamoto C, Maekawa M, Takagai S, Wakuda T, Kameno Y, Kurita D, Yamada K, Kikuchi M, Hashimoto T, Kanahara N, et al. Comprehensive association analysis of 27 genes from the GABAergic system in Japanese individuals affected with schizophrenia. Schizophrenia Research. PMID 28073605 DOI: 10.1016/J.Schres.2017.01.003 |
0.597 |
|
2016 |
Toyoshima M, Akamatsu W, Okada Y, Ohnishi T, Balan S, Hisano Y, Iwayama Y, Toyota T, Matsumoto T, Itasaka N, Sugiyama S, Tanaka M, Yano M, Dean B, Okano H, et al. Analysis of induced pluripotent stem cells carrying 22q11.2 deletion. Translational Psychiatry. 6: e934. PMID 27801899 DOI: 10.1038/Tp.2016.206 |
0.317 |
|
2016 |
Maekawa M, Iwayama Y, Ohnishi T, Toyoshima M, Shimamoto C, Hisano Y, Toyota T, Balan S, Matsuzaki H, Iwata Y, Takagai S, Yamada K, Ota M, Fukuchi S, Okada Y, et al. Erratum: Investigation of the fatty acid transporter-encoding genes SLC27A3 and SLC27A4 in autism. Scientific Reports. 6: 20268. PMID 26822806 DOI: 10.1038/Srep20268 |
0.439 |
|
2015 |
Maekawa M, Iwayama Y, Ohnishi T, Toyoshima M, Shimamoto C, Hisano Y, Toyota T, Balan S, Matsuzaki H, Iwata Y, Takagai S, Yamada K, Ota M, Fukuchi S, Okada Y, et al. Investigation of the fatty acid transporter-encoding genes SLC27A3 and SLC27A4 in autism. Scientific Reports. 5: 16239. PMID 26548558 DOI: 10.1038/Srep16239 |
0.527 |
|
2015 |
Bangel FN, Yamada K, Arai M, Iwayama Y, Balan S, Toyota T, Iwata Y, Suzuki K, Kikuchi M, Hashimoto T, Kanahara N, Mori N, Itokawa M, Stork O, Yoshikawa T. Genetic analysis of the glyoxalase system in schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 59: 105-10. PMID 25645869 DOI: 10.1016/J.Pnpbp.2015.01.014 |
0.597 |
|
2015 |
Maekawa M, Yamada K, Toyoshima M, Ohnishi T, Iwayama Y, Shimamoto C, Toyota T, Nozaki Y, Balan S, Matsuzaki H, Iwata Y, Suzuki K, Miyashita M, Kikuchi M, Kato M, et al. Utility of Scalp Hair Follicles as a Novel Source of Biomarker Genes for Psychiatric Illnesses. Biological Psychiatry. 78: 116-25. PMID 25444170 DOI: 10.1016/J.Biopsych.2014.07.025 |
0.504 |
|
2015 |
Balan S, Iwayama Y, Yamada K, Toyota T, Ohnishi T, Toyoshima M, Shimamoto C, Ide M, Iwata Y, Suzuki K, Kikuchi M, Hashimoto T, Kanahara N, Yoshikawa T, Maekawa M. Sequencing and expression analyses of the synaptic lipid raft adapter gene PAG1 in schizophrenia. Journal of Neural Transmission (Vienna, Austria : 1996). 122: 477-85. PMID 25005592 DOI: 10.1007/s00702-014-1269-0 |
0.593 |
|
2014 |
Balan S, Iwayama Y, Maekawa M, Toyota T, Ohnishi T, Toyoshima M, Shimamoto C, Esaki K, Yamada K, Iwata Y, Suzuki K, Ide M, Ota M, Fukuchi S, Tsujii M, et al. Exon resequencing of H3K9 methyltransferase complex genes, EHMT1, EHTM2 and WIZ, in Japanese autism subjects. Molecular Autism. 5: 49. PMID 25400900 DOI: 10.1186/2040-2392-5-49 |
0.535 |
|
2014 |
Balan S, Iwayama Y, Toyota T, Toyoshima M, Maekawa M, Yoshikawa T. 22q11.2 deletion carriers and schizophrenia-associated novel variants. The British Journal of Psychiatry : the Journal of Mental Science. 204: 398-9. PMID 24482440 DOI: 10.1192/bjp.bp.113.138420 |
0.377 |
|
2013 |
Balan S, Yamada K, Hattori E, Iwayama Y, Toyota T, Ohnishi T, Maekawa M, Toyoshima M, Iwata Y, Suzuki K, Kikuchi M, Yoshikawa T. Population-specific haplotype association of the postsynaptic density gene DLG4 with schizophrenia, in family-based association studies. Plos One. 8: e70302. PMID 23936182 DOI: 10.1371/journal.pone.0070302 |
0.59 |
|
2013 |
Balan S, Yamada K, Iwayama Y, Toyota T, Ohnishi T, Maekawa M, Toyoshima M, Iwata Y, Suzuki K, Kikuchi M, Ujike H, Inada T, Kunugi H, Ozaki N, Iwata N, et al. Lack of association of EGR2 variants with bipolar disorder in Japanese population. Gene. 526: 246-50. PMID 23747400 DOI: 10.1016/j.gene.2013.05.055 |
0.518 |
|
Show low-probability matches. |